From Barcelona to Wall Street — Dr. Josep Bassaganya-Riera’s journey is nothing short of extraordinary. A veterinarian-turned-immunologist, he went on to found multiple biotech companies, take Landos Biopharma public, and lead one of the only private biotech firms with a Phase 3 asset in IBD.
In this episode, we dive deep into:
How Josep transitioned from academia to biotech entrepreneurship (Landos and NImmune)
Raising capital in a tough biotech market
The art of picking the right bankers for an IPO
Building alignment with investors & the buy side
How AI and computational immunology are reshaping drug discovery
The lessons he learned taking a company from paper to IPO to acquisition